Medpace Holdings, Inc. (MEDP) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
MEDP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MEDP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 30.1% | 21.1% | 17.8% |
| 2024 | 31.1% | 21.2% | 19.2% |
| 2023 | 27.8% | 17.9% | 15.0% |
| 2022 | 29.6% | 19.1% | 16.8% |
| 2021 | 28.7% | 17.4% | 15.9% |
Download Data
Export MEDP earnings history in CSV or JSON format
Free sign-in required to download data
Medpace Holdings, Inc. (MEDP) Earnings Overview
As of May 8, 2026, Medpace Holdings, Inc. (MEDP) reported trailing twelve-month net income of $460M, reflecting +21.0% year-over-year growth. The company earned $15.90 per diluted share over the past four quarters, with a net profit margin of 17.8%.
Looking at the long-term picture, MEDP's 5-year EPS compound annual growth rate (CAGR) stands at +31.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $451M in fiscal 2025, representing a new all-time high.
Medpace Holdings, Inc. maintains industry-leading profitability with a gross margin of 30.1%, operating margin of 21.1%, and net margin of 17.8%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ICLR ($599M net income, 9.6% margin), CRL (-$185M net income, -3.6% margin), PRA ($65M net income, 4.6% margin), MEDP has outperformed on profitability metrics. Compare MEDP vs ICLR →
MEDP Earnings vs Peers
Earnings metrics vs comparable public companies
MEDP Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $451M | +11.6% | $535M | $15.28 | 17.8% | 21.1% |
| 2024 | $404M | +43.0% | $447M | $12.63 | 19.2% | 21.2% |
| 2023 | $283M | +15.3% | $337M | $8.88 | 15.0% | 17.9% |
| 2022 | $245M | +34.9% | $279M | $7.28 | 16.8% | 19.1% |
| 2021 | $182M | +25.1% | $199M | $4.81 | 15.9% | 17.4% |
| 2020 | $145M | +44.7% | $167M | $3.84 | 15.7% | 18.0% |
| 2019 | $100M | +37.2% | $127M | $2.67 | 11.7% | 14.8% |
| 2018 | $73M | +87.1% | $101M | $1.97 | 10.4% | 14.3% |
| 2017 | $39M | +191.4% | $65M | $0.98 | 9.0% | 14.9% |
| 2016 | $13M | +254.8% | $52M | $0.37 | 3.2% | 12.5% |
Full MEDP Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MEDP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MEDP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MEDP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMEDP — Frequently Asked Questions
Quick answers to the most common questions about buying MEDP stock.
Is MEDP growing earnings?
MEDP EPS is $15.90, with earnings growth accelerating to +21.0%. This exceeds the 5-year CAGR of +31.8%. TTM net income reached $460M.
What are MEDP's profit margins?
Medpace Holdings, Inc. net margin is +17.8%, with operating margin at +21.1%. Above-average margins indicate pricing power.
How consistent are MEDP's earnings?
MEDP earnings data spans 2014-2025. The accelerating earnings trend is +21.0% YoY. Historical data enables comparison across business cycles.